119-hres65

HRES
✓ Complete Data

Reaffirming the freedom to decide and expressing continued support for medication abortion access.

Login to track bills
Introduced:
Jan 24, 2025
Policy Area:
Health

Bill Statistics

3
Actions
0
Cosponsors
0
Summaries
5
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Jan 24, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Actions (3)

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral | Source: House floor actions | Code: H11100
Jan 24, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Type: IntroReferral | Source: House floor actions | Code: H11100
Jan 24, 2025
Submitted in House
Type: Committee | Source: Library of Congress | Code: H12100
Jan 24, 2025

Subjects (5)

Abortion Drug therapy Health (Policy Area) Postal service Prescription drugs

Text Versions (1)

Introduced in House

Jan 24, 2025

Full Bill Text

Length: 2,835 characters Version: Introduced in House Version Date: Jan 24, 2025 Last Updated: Nov 12, 2025 6:29 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 65 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. RES. 65

Reaffirming the freedom to decide and expressing continued support for
medication abortion access.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

January 24, 2025

Mr. Gottheimer submitted the following resolution; which was referred
to the Committee on Energy and Commerce, and in addition to the
Committee on the Judiciary, for a period to be subsequently determined
by the Speaker, in each case for consideration of such provisions as
fall within the jurisdiction of the committee concerned

_______________________________________________________________________

RESOLUTION

Reaffirming the freedom to decide and expressing continued support for
medication abortion access.

Whereas antiabortion extremists are desperate to ban abortion nationwide and are
trying to misuse a centuries-old zombie law to achieve their goals;
Whereas there is a settled understanding of the Comstock Act for nearly a
century, and the Department of Justice, the courts, and Congress have
made clear that the Comstock laws do not apply to lawful abortions;
Whereas the majority of the public supports abortion access, and an overwhelming
majority of Americans (80 percent) oppose a Federal law banning abortion
nationwide;
Whereas antiabortion extremists are waging a war on reproductive rights,
including the ability to make personal, private health care decisions;
Whereas misusing, misapplying, and misinterpreting the Comstock Act would be yet
another attempt to attack access to medication abortion, a safe and
effective health care option;
Whereas misusing, misapplying, and misinterpreting the Comstock Act could
threaten certain shipping and transportation of basic medical materials;
and
Whereas misusing, misapplying, and misinterpreting the Comstock Act could
further threaten and endanger sexual and reproductive health: Now,
therefore, be it
Resolved, That the House of Representatives--

(1) affirms the existing authority to distribute medication
abortion under Federal law, as confirmed by the December 23,
2022, Department of Justice's Office of Legal Counsel
Memorandum Opinion for the General Counsel of the United States
Postal Service which states in part that ``
Section 1461 of title 18 of the U.
title 18 of the U.S. Code does not prohibit the mailing of
certain drugs that can be used to perform abortions where the
sender lacks the intent that the recipient of the drugs will
use them unlawfully.''; and

(2) condemns restrictions on access to and coverage of
reproductive health care, including medication abortion like
mifepristone.
<all>